CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...